Status: current, Not sufficiently defined by necessary conditions definition status. Date: 25-Nov 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2311251000001115 | Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 2311261000001117 | Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has excipient | Excipient not declared | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Is a | Ozanimod 230microgram capsules and Ozanimod 460microgram capsules 7 capsule | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Legal category | Prescription only medicine - legal category (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has AMP | Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Discontinued indicator | Never discontinued | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Is a | Actual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has dispensed dose form | Dose form not applicable (qualifier value) | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator | NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has excipient | Propylene glycol | false | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator | EMA (European Medicines Agency) monitoring | true | Inferred relationship | Existential restriction modifier | ||
| Zeposia 0.23mg/0.46mg capsules treatment initiation pack (Bristol-Myers Squibb Pharmaceuticals Ltd) 7 capsule 1 x (4 caps + 3 caps) | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR